デジタル治療(DTx)の世界市場：2025年に至る販売チャンネル別、用途別予測【市場調査レポート】

次世代エネルギー産業・グリーン経済の国際リサーチ情報サイト

デジタル治療(DTx)の世界市場：2025年に至る販売チャンネル別、用途別予測

Digital Therapeutic (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel (B2C, Patient, Caregiver, B2B, Providers, Payer, Employer, Pharma) - Global forecasts to 2025

出版元：MarketsandMarkets出版元について
発行年：2020年3月
定価 Single User License(1名様ライセンス)US$5,650(米国ドル)/Multi User License(5名様)$6,650 /Corporate User License $8,150
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算（お見積り日TTSレート）となります。
納品形態：PDF by Email
当調査レポートは英文166ページになります。
商品コード：MAM1937

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】
デジタル治療(DTx)は今後急速な普及が期待され、その世界市場規模は2020年の推計21億ドルから2025年には69億ドルにまで増加すると予測されます。当レポートでは、2025年に至るデジタル治療(DTx)の世界市場予測(市場規模US$)、販売チャンネル別市場（B2B各種、B2C各種）、用途別市場（治療/ケア関連用途各種、予防用途各種）、主要国地域別市場など、詳細な市場予測データと分析を掲載しています。また市場分析、競合状況、主要メーカー企業21社プロフィール動向などの情報も交えて、デジタル治療(DTx)市場の現在と今後展開を予測分析していきます。

【レポート構成概要】
◆デジタル治療(DTx)の世界市場予測2018-2025年
・市場規模(US$)

◆販売チャンネル別、市場-2025年
B2B
・医療費負担者
・雇用者
・製薬会社
・医療提供者
・その他
B2C
・介護者
・患者
※(市場規模US$)

◆用途別、市場-2025年
治療/ケア関連用途
・糖尿病
・中枢神経系障害
・禁煙
・慢性呼吸器疾患
・筋骨格障害
・心血管疾患
・服薬アドヒアランス
・胃腸疾患
・リハビリテーション/患者ケア
・物質使用障害/依存症管理
・その他

予防用途
・糖尿病予備軍
・肥満
・栄養
・ライフスタイル管理
・その他
※(市場規模US$)

◆主要国地域別市場-2025年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・スペイン、イタリア
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
その他地域
※国地域別に全セグメントの細分化データ掲載、詳細は目次参照

◆市場分析
・市場ダイナミクス分析（ドライバー、障壁、機会、課題）
・競合状況

◆デジタル治療(DTx)の主要企業プロフィール動向
・NOOM
・LIVONGO HEALTH
・OMADA HEALTH
・COGNIFIT
・PROTEUS DIGITAL HEALTH
・WELLDOC
・GINGER
・PROPELLER HEALTH
・MORROW
・CANARY HEALTH
・MANGO HEALTH INC.
・CLICK THERAPEUTICS
・PEAR THERAPEUTICS
・AKILI INTERACTIVE LABS
・WELLTHY THERAPEUTICS
・COGNOA
・HAPPIFY
・KAIA HEALTH
・AYOGO HEALTH
・BETTER THERAPEUTICS
・MINDSTRONG HEALTH
（全166頁）

【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

英文詳細目次(table of contents)

【原文詳細目次】

Digital Therapeutic (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel (B2C, Patient, Caregiver, B2B, Providers, Payer, Employer, Pharma) - Global forecasts to 2025

Table of Contents

1 INTRODUCTION 19

1.1         OBJECTIVES OF THE STUDY      19
1.2         MARKET DEFINITION   19
1.2.1      MARKETS COVERED     20
1.2.2      YEARS CONSIDERED FOR THE STUDY   20
1.3         CURRENCY        21
1.4         LIMITATIONS   21
1.5         STAKEHOLDERS            21
1.6         LIMITATIONS   21

2 RESEARCH METHODOLOGY 22

2.1         RESEARCH DATA           22
2.1.1      SECONDARY DATA       23
2.1.1.1   KEY DATA FROM SECONDARY SOURCES            24
2.1.2      PRIMARY DATA 25
2.1.2.1   KEY DATA FROM PRIMARY SOURCES    26
2.1.2.2   KEY INDUSTRY INSIGHTS          27
2.2         MARKET SIZE ESTIMATION       29
2.2.1      BOTTOM-UP APPROACH           29
2.2.1.1   APPROACH ONE: REVENUE MAPPING-BASED ESTIMATION       29
2.2.1.2   APPROACH TWO: BUYER ADOPTION-BASED ESTIMATION        30
2.2.2      TOP-DOWN APPROACH: PENETRATION RATE-BASED MARKET SIZE ESTIMATION    31
2.2.3      GROWTH FORECAST    31
2.3         MARKET BREAKDOWN AND DATA TRIANGULATION    33
2.4         MARKET PLAYER RANKING       34
2.5         ASSUMPTIONS FOR THE STUDY             34

3 EXECUTIVE SUMMARY 35

4 PREMIUM INSIGHTS 40

4.1         DIGITAL THERAPEUTICS MARKET OVERVIEW 40
4.2         DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2025              41
4.3         B2B SALES CHANNEL MARKET SHARE, BY BUYER & REGION (2019)              42
4.4         DIGITAL THERAPEUTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES           43

5 MARKET OVERVIEW 44

5.1         INTRODUCTION            44
5.2         MARKET DYNAMICS     44
5.2.1      DRIVERS            45
5.2.1.1   INCREASING INCIDENCE OF PREVENTABLE CHRONIC DISEASES              45
5.2.1.2   RISING FOCUS ON PREVENTIVE HEALTHCARE 45
5.2.1.3   NEED TO CONTROL HEALTHCARE COSTS         46
5.2.1.4   SIGNIFICANT INCREASE IN VENTURE CAPITAL INVESTMENTS 46
5.2.1.5   BENEFITS OF DIGITAL THERAPEUTICS 47
5.2.1.5.1 ABILITY TO INDUCE BEHAVIORAL CHANGE     47
5.2.1.5.2 IMPROVED DRUG ADHERENCE 47
5.2.1.5.3 PATIENT CONVENIENCE AND USER-FRIENDLINESS      48
5.2.2      RESTRAINTS     48
5.2.2.1   PATIENT DATA PRIVACY CONCERNS    48
5.2.3      OPPORTUNITIES           49
5.2.3.1   EMERGING MARKETS   49
5.2.3.2   LARGE UNDIAGNOSED AND UNTREATED POPULATION            49
5.2.3.3   UNEXPLORED THERAPEUTIC APPLICATIONS   49
5.2.4      CHALLENGES   50
5.2.4.1   UNSTABLE PAYMENT MODELS 50
5.2.4.2   RELUCTANCE AMONG PATIENTS TO ADOPT DIGITAL THERAPEUTICS              50
5.2.4.3   LACK OF AWARENESS AND ACCESS TO DIGITAL THERAPEUTICS PROGRAMS IN DEVELOPING COUNTRIES          50
5.2.4.4   RESISTANCE FROM TRADITIONAL HEALTHCARE PROVIDERS   51

6 DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL 52

6.1         INTRODUCTION            53
6.2         B2B       53
6.2.1      PAYERS 54
6.2.1.1   PAYERS HOLD THE HIGHEST SHARE OF THE MARKET, BY B2B SALES              54
6.2.2      EMPLOYERS     55
6.2.2.1   IMPORTANCE OF EMPLOYEE HEALTH MANAGEMENT IS PROPELLING THE ADOPTION OF DIGITAL THERAPEUTICS AMONG EMPLOYERS       55
6.2.3      PHARMACEUTICAL COMPANIES            56
6.2.3.1   CROSS-INDUSTRY COLLABORATION BETWEEN DIGITAL THERAPEUTICS START-UPS AND PHARMACEUTICAL COMPANIES WILL DRIVE MARKET GROWTH        56
6.2.4      PROVIDERS       57
6.2.4.1   POTENTIAL FOR BETTER PATIENT MANAGEMENT AND COST-REDUCTIONS ARE DRIVING DEMAND FOR DIGITAL THERAPEUTICS AMONG PROVIDERS       57
6.2.5      OTHER BUYERS              58
6.3         B2C       58
6.3.1      CAREGIVERS     59
6.3.1.1   EASE OF MANAGING HEALTH CONDITIONS HAS DRIVEN DEMAND FOR SOLUTIONS AMONG CAREGIVERS 59
6.3.2      PATIENTS         60
6.3.2.1   AWARENESS ABOUT PREVENTIVE HEALTH AMONG PATIENTS WILL DRIVE THE GROWTH OF THIS SEGMENT           60

7 DIGITAL THERAPEUTICS MARKET, BY APPLICATION 61

7.1         INTRODUCTION            62
7.2         TREATMENT/CARE-RELATED APPLICATIONS 62
7.2.1      DIABETES         64
7.2.1.1   GROWING PREVALENCE OF DIABETES DRIVES MARKET GROWTH              64
7.2.2      CENTRAL NERVOUS SYSTEM DISORDERS          64
7.2.2.1   POTENTIAL BENEFITS OF DIGITAL THERAPEUTICS IN CNS DISORDER MANAGEMENT HAVE DRIVEN THE DEVELOPMENT OF SOLUTIONS      64
7.2.3      SMOKING CESSATION 65
7.2.3.1   FOCUS ON PROVIDING CLINICALLY VALIDATED, EFFECTIVE MOBILE APPLICATIONS TO HELP QUIT SMOKING DRIVES MARKET GROWTH   65
7.2.4      CHRONIC RESPIRATORY DISEASES        66
7.2.4.1   GROWING PREVALENCE OF COPD AND ASTHMA IS RESPONSIBLE FOR MARKET GROWTH IN THIS SEGMENT 66
7.2.5      MUSCULOSKELETAL DISORDERS          67
7.2.5.1   POTENTIAL OF DIGITAL THERAPEUTICS IN PAIN MANAGEMENT TO DRIVE THE ADOPTION OF THESE SOLUTIONS AMONG END USERS       67
7.2.6      CARDIOVASCULAR DISEASES   67
7.2.6.1   INCREASING COSTS OF CARE DRIVE THE NEED FOR DIGITAL THERAPEUTICS SOLUTIONS     67
7.2.7      MEDICATION ADHERENCE       68
7.2.7.1   NEED TO DRIVE MEDICATION ADHERENCE RATES HAS PROPELLED THE DEMAND FOR EFFECTIVE SOLUTIONS      68
7.2.8      GASTROINTESTINAL DISORDERS          69
7.2.8.1   AVAILABILITY OF MOBILE APPLICATIONS FOR THE MANAGEMENT OF GI CONDITIONS TO DRIVE THE MARKET GROWTH       69
7.2.9      REHABILITATION & PATIENT CARE       70
7.2.9.1   BENEFITS OF DIGITAL THERAPEUTICS HAVE INDUCED STARTUPS TO DEVELOP PLATFORMS FOR PATIENT CARE       70
7.2.10    SUBSTANCE USE DISORDERS & ADDICTION MANAGEMENT      70
7.2.10.1 POTENTIAL TO IMPROVE THE EFFICIENCY OF BEHAVIORAL INTERVENTIONS ARE ENCOURAGING MARKET GROWTH          70
7.2.11    OTHER TREATMENT/CARE-RELATED APPLICATIONS 71
7.3         PREVENTIVE APPLICATIONS    72
7.3.1      PREDIABETES 73
7.3.1.1   INFLUX OF STARTUPS TO PROVIDE EFFECTIVE PREVENTION AGAINST PREDIABETES DRIVES THE GROWTH OF THIS SEGMENT        73
7.3.2      OBESITY            74
7.3.2.1   AVAILABILITY OF COST-EFFECTIVE SOLUTIONS FOR OBESITY MANAGEMENT PROPELS THE GROWTH OF THIS SEGMENT      74
7.3.3      NUTRITION       74
7.3.3.1   IMPORTANCE OF NUTRITION IN PREVENTING A WIDE RANGE OF AILMENTS HAS DRIVEN DEMAND FOR DIGITAL THERAPEUTIC SOLUTIONS              74
7.3.4      LIFESTYLE MANAGEMENT        75
7.3.4.1   ABILITY OF DIGITAL THERAPEUTICS SOLUTIONS TO INDUCE POSITIVE BEHAVIORAL CHANGES HAS CONTRIBUTED TO THE RISE IN DEMAND           75
7.3.5      OTHER PREVENTIVE APPLICATIONS    76

8 DIGITAL THERAPEUTICS MARKET, BY REGION 77

8.1         INTRODUCTION            78
8.2         NORTH AMERICA          78
8.2.1      US         83
8.2.1.1   MAJOR DIGITAL THERAPEUTICS START-UPS ARE BASED OUT OF THE US, WHICH HAS GREATLY SUPPORTED ACCESS TO SOLUTIONS             83
8.2.2      CANADA            86
8.2.2.1   EFFORTS ARE BEING TAKEN BY THE CANADIAN GOVERNMENT TO SUPPORT DIGITAL THERAPEUTICS       86
8.3         EUROPE             89
8.3.1      GERMANY         94
8.3.1.1   GERMANY ACCOUNTED FOR THE LARGEST SHARE OF THE DIGITAL THERAPEUTICS MARKET IN EUROPE    94
8.3.2      UK         97
8.3.2.1   WELL-ESTABLISHED HEALTHCARE SYSTEM AND GOVERNMENT SUPPORT WILL PROPEL THE GROWTH OF THE MARKET           97
8.3.3      FRANCE             100
8.3.3.1   GROWING HEALTHCARE EXPENDITURE AND FAVORABLE HEALTH INSURANCE SYSTEM TO SUPPORT MARKET GROWTH IN FRANCE         100
8.3.4      SPAIN   103
8.3.4.1   INITIATIVES BY EMERGING DIGITAL THERAPEUTICS STARTUPS ARE SUPPORTING MARKET GROWTH           103
8.3.5      ITALY   106
8.3.5.1   NEED FOR ALTERNATIVE AND EFFECTIVE TREATMENT TO DRIVE THE MARKET GROWTH IN THE COMING YEARS             106
8.3.6      REST OF EUROPE           109
8.4         ASIA PACIFIC    112
8.4.1      JAPAN 115
8.4.1.1   RISING DIABETES INCIDENCE AND COLLABORATIONS BETWEEN STAKEHOLDERS ARE INDICATORS OF MARKET GROWTH IN JAPAN      115
8.4.2      CHINA 118
8.4.2.1   GROWING GERIATRIC POPULATION AND INCIDENCE OF CHRONIC CONDITIONS WILL DRIVE DEMAND FOR DIGITAL THERAPEUTICS IN CHINA              118
8.4.3      INDIA   121
8.4.3.1   RISING CHRONIC DISEASE INCIDENCE AND THE NEED FOR BETTER DISEASE MANAGEMENT DRIVE MARKET GROWTH        121
8.4.4      REST OF APAC 124
8.5         REST OF THE WORLD   126

9 COMPETITIVE LANDSCAPE 129

9.1         OVERVIEW        129
9.2         MARKET RANKING ANALYSIS, 2019        130
9.3         COMPETITIVE LEADERSHIP MAPPING 131
9.3.1      VISIONARY LEADERS    131
9.3.2      DYNAMIC DIFFERENTIATORS   131
9.3.3      INNOVATORS   131
9.3.4      EMERGING COMPANIES             131
9.4         COMPETITIVE SITUATION AND TRENDS           133
9.4.1      PRODUCT LAUNCHES 133
9.4.2      EXPANSIONS    133
9.4.3      PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS            134

10 COMPANY PROFILES 135

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW)*
10.1       NOOM 135
10.2       LIVONGO HEALTH        136
10.3       OMADA HEALTH           137
10.4       COGNIFIT         139
10.5       PROTEUS DIGITAL HEALTH      141
10.6       WELLDOC         142
10.7       GINGER             143
10.8       PROPELLER HEALTH    144
10.9       2MORROW        145
10.10     CANARY HEALTH          146
10.11     MANGO HEALTH INC.   147
10.12     CLICK THERAPEUTICS 148
10.13     PEAR THERAPEUTICS   149
10.14     AKILI INTERACTIVE LABS          151
10.15     WELLTHY THERAPEUTICS        152
10.16     COGNOA           153
10.17     HAPPIFY            154
10.18     KAIA HEALTH 155
10.19     AYOGO HEALTH            156
10.20     BETTER THERAPEUTICS            157
10.21     MINDSTRONG HEALTH             158
*BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
11          APPENDIX         159

LIST OF TABLES

TABLE 1             FACTOR ANALYSIS        32
TABLE 2             DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2018–2025 (USD MILLION)     53
TABLE 3             DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER,
2018–2025 (USD MILLION)          53
TABLE 4             DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY REGION,
2018–2025 (USD MILLION)          54
TABLE 5             DIGITAL THERAPEUTICS MARKET FOR PAYERS, BY REGION,
2018–2025 (USD MILLION)          55
TABLE 6             DIGITAL THERAPEUTICS MARKET FOR EMPLOYERS, BY REGION,
2018–2025 (USD MILLION)          56
TABLE 7             DIGITAL THERAPEUTICS MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2018–2025 (USD MILLION)      57
TABLE 8             DIGITAL THERAPEUTICS MARKET FOR PROVIDERS, BY REGION,
2018–2025 (USD MILLION)          58
TABLE 9             DIGITAL THERAPEUTICS MARKET FOR OTHER BUYERS, BY REGION,
018–2025 (USD MILLION)            58
TABLE 10           DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER,
2018–2025 (USD MILLION)          59
TABLE 11           DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY REGION,
2018–2025 (USD MILLION)          59
TABLE 12           DIGITAL THERAPEUTICS MARKET FOR CAREGIVERS, BY REGION,
2018–2025 (USD MILLION)          60
TABLE 13           DIGITAL THERAPEUTICS MARKET FOR PATIENTS, BY REGION,
2018–2025 (USD MILLION)          60
TABLE 14           DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)     62
TABLE 15           DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION) 63
TABLE 16           DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)           63
TABLE 17           DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY REGION,
2018–2025 (USD MILLION)          64
TABLE 18           DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY REGION,
2018–2025 (USD MILLION)          65
TABLE 19           DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY REGION,
2018–2025 (USD MILLION)          66
TABLE 20           DIGITAL THERAPEUTICS MARKET FOR CHRONIC RESPIRATORY DISEASES,
BY REGION, 2018–2025 (USD MILLION) 66
TABLE 21           DIGITAL THERAPEUTICS MARKET FOR MUSCULOSKELETAL DISORDERS,
BY REGION, 2018–2025 (USD MILLION) 67
TABLE 22           DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2018–2025 (USD MILLION)           68
TABLE 23           DIGITAL THERAPEUTICS MARKET FOR MEDICATION ADHERENCE, BY REGION, 2018–2025 (USD MILLION)     69
TABLE 24           DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDERS,
BY REGION, 2018–2025 (USD MILLION) 69
TABLE 25           DIGITAL THERAPEUTICS MARKET FOR REHABILITATION & PATIENT CARE,
BY REGION, 2018–2025 (USD MILLION) 70
TABLE 26           DIGITAL THERAPEUTICS MARKET FOR SUBSTANCE USE DISORDERS & ADDICTION MANAGEMENT, BY REGION, 2018–2025 (USD MILLION)          71
TABLE 27           DIGITAL THERAPEUTICS MARKET FOR OTHER TREATMENT/CARE-RELATED APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)          71
TABLE 28           DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)      72
TABLE 29           DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 73
TABLE 30           DIGITAL THERAPEUTICS MARKET FOR PREDIABETES, BY REGION,
2018–2025 (USD MILLION)          73
TABLE 31           DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY REGION,
2018–2025 (USD MILLION)          74
TABLE 32           DIGITAL THERAPEUTICS MARKET FOR NUTRITION, BY REGION,
2018–2025 (USD MILLION)          75
TABLE 33           DIGITAL THERAPEUTICS MARKET FOR LIFESTYLE MANAGEMENT, BY REGION, 2018–2025 (USD MILLION) 75
TABLE 34           DIGITAL THERAPEUTICS MARKET FOR OTHER PREVENTIVE APPLICATIONS,
BY REGION, 2018–2025 (USD MILLION) 76
TABLE 35           DIGITAL THERAPEUTICS MARKET, BY REGION, 2018–2025 (USD MILLION) 78
TABLE 36           NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY COUNTRY,
2018–2025 (USD MILLION)          80
TABLE 37           NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION)          80
TABLE 38           NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)          81
TABLE 39           NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)          81
TABLE 40           NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL,
2018–2025 (USD MILLION)          82
TABLE 41           NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    82
TABLE 42           NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    82
TABLE 43           US: DIGITAL THERAPEUTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION)          84
TABLE 44           US: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)          84
TABLE 45           US: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)      85
TABLE 46           US: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL,
2018–2025 (USD MILLION)          85
TABLE 47           US: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER,
2018–2025 (USD MILLION)          85
TABLE 48           US: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018–2025 (USD MILLION)            86
TABLE 49          CANADA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION)          87
TABLE 50           CANADA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)          87
TABLE 51           CANADA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS,
BY TYPE, 2018–2025 (USD MILLION)       88
TABLE 52           CANADA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL,
2018–2025 (USD MILLION)          88
TABLE 53           CANADA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018–2025 (USD MILLION)            88
TABLE 54           CANADA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018–2025 (USD MILLION)            89
TABLE 55           EUROPE: DIGITAL THERAPEUTICS MARKET, BY COUNTRY,
2018–2025 (USD MILLION)          91
TABLE 56           EUROPE: DIGITAL THERAPEUTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION)          91
TABLE 57           EUROPE: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)          92
TABLE 58           EUROPE: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS,
BY TYPE, 2018–2025 (USD MILLION)       92
TABLE 59           EUROPE: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL,
2018–2025 (USD MILLION)          93
TABLE 60           EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    93
TABLE 61           EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    93
TABLE 62           GERMANY: DIGITAL THERAPEUTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION)          94
TABLE 63           GERMANY: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)          95
TABLE 64           GERMANY: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS,
BY TYPE, 2018–2025 (USD MILLION)       95
TABLE 65           GERMANY: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL,
2018–2025 (USD MILLION)          96
TABLE 66           GERMANY: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018–2025 (USD MILLION)            96
TABLE 67           GERMANY: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018–2025 (USD MILLION)            96
TABLE 68           UK: DIGITAL THERAPEUTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION)          97
TABLE 69           UK: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)          98
TABLE 70           UK: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS,
BY TYPE, 2018–2025 (USD MILLION)       98
TABLE 71           UK: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL,
2018–2025 (USD MILLION)          99
TABLE 72           UK: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    99
TABLE 73           UK: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    99
TABLE 74           FRANCE: DIGITAL THERAPEUTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION)          100
TABLE 75           FRANCE: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)          101
TABLE 76           FRANCE: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS,
BY TYPE, 2018–2025 (USD MILLION)       101
TABLE 77           FRANCE: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL,
2018–2025 (USD MILLION)          102
TABLE 78           FRANCE: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    102
TABLE 79           FRANCE: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    102
TABLE 80           SPAIN: DIGITAL THERAPEUTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION)          103
TABLE 81           SPAIN: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)          104
TABLE 82           SPAIN: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)      104
TABLE 83          SPAIN: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL,
2018–2025 (USD MILLION)          105
TABLE 84           SPAIN: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    105
TABLE 85           SPAIN: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    105
TABLE 86           ITALY: DIGITAL THERAPEUTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION)          106
TABLE 87           ITALY: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)          107
TABLE 88           ITALY: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS,
BY TYPE, 2018–2025 (USD MILLION)       107
TABLE 89          ITALY: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL,
2018–2025 (USD MILLION)          108
TABLE 90           ITALY: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    108

TABLE 91 ITALY: DIGITAL THERAPEUTICS MARKET FOR B2B SALES

CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    108
TABLE 92           ROE: DIGITAL THERAPEUTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION)          109
TABLE 93           ROE: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)          110
TABLE 94           ROE: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS,
BY TYPE, 2018–2025 (USD MILLION)       110
TABLE 95           ROE: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL,
2018–2025 (USD MILLION)          111
TABLE 96           ROE: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    111
TABLE 97           ROE: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    111
TABLE 98           APAC: DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)     112
TABLE 99           APAC: DIGITAL THERAPEUTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION)          112
TABLE 100         APAC: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)          113
TABLE 101         APAC: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)      113
TABLE 102         APAC: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL,
2018–2025 (USD MILLION)          114
TABLE 103         APAC: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018–2025 (USD MILLION)            114
TABLE 104         APAC: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018–2025 (USD MILLION)            114
TABLE 105         JAPAN: DIGITAL THERAPEUTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION)          115
TABLE 106         JAPAN: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)          116
TABLE 107         JAPAN: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS,
BY TYPE, 2018–2025 (USD MILLION)       116
TABLE 108        JAPAN: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL,
2018–2025 (USD MILLION)          117
TABLE 109         JAPAN: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018–2025 (USD MILLION)            117
TABLE 110         JAPAN: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018–2025 (USD MILLION)            117
TABLE 111         CHINA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION)          118
TABLE 112         CHINA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)          119
TABLE 113         CHINA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS,
BY TYPE, 2018–2025 (USD MILLION)       119
TABLE 114         CHINA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL,
2018–2025 (USD MILLION)          120
TABLE 115         CHINA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    120
TABLE 116         CHINA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    120
TABLE 117         INDIA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION)          121
TABLE 118         INDIA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)          122
TABLE 119         INDIA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS,
BY TYPE, 2018–2025 (USD MILLION)       122
TABLE 120        INDIA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL,
2018–2025 (USD MILLION)          123
TABLE 121         INDIA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    123
TABLE 122         INDIA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    123
TABLE 123        ROAPAC: DIGITAL THERAPEUTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION)          124
TABLE 124         ROAPAC: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)          124
TABLE 125         ROAPAC: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS,
BY TYPE, 2018–2025 (USD MILLION)       125
TABLE 126         ROAPAC: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL,
2018–2025 (USD MILLION)          125
TABLE 127         ROAPAC: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    125
TABLE 128         ROAPAC: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL,
BY BUYER, 2018–2025 (USD MILLION)    126
TABLE 129         ROW: DIGITAL THERAPEUTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION)          126
TABLE 130         ROW: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-BASED APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)          127
TABLE 131         ROW: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS,
BY TYPE, 2018–2025 (USD MILLION)       127
TABLE 132         ROW: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL,
2018–2025 (USD MILLION)          128
TABLE 133         ROW: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2018–2025 (USD MILLION)            128
TABLE 134         ROW: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2018–2025 (USD MILLION)            128

LIST OF FIGURES

FIGURE 1           RESEARCH DESIGN       22
FIGURE 2           PRIMARY SOURCES       25
FIGURE 3           BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 28
FIGURE 4           BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY TYPE OF
BUYER AND REGION     28
FIGURE 5           ESTIMATION OF THE DIGITAL THERAPEUTICS MARKET: REVENUE MAPPING-BASED ESTIMATION          30
FIGURE 6           MARKET SIZE ESTIMATION: BUYER ADOPTION-BASED 30
FIGURE 7           PENETRATION RATE-BASED MARKET ESTIMATION      31
FIGURE 8           DATA TRIANGULATION METHODOLOGY         33
FIGURE 9           DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL,
2020 VS. 2025 (USD MILLION)     35
FIGURE 10         CAREGIVERS SEGMENT TO REGISTER SIGNIFICANT GROWTH DURING THE FORECAST PERIOD           36
FIGURE 11         PAYERS TO DOMINATE THE DIGITAL THERAPEUTICS MARKET DURING THE FORECAST PERIOD        36
FIGURE 12         DIGITAL THERAPEUTICS MARKET, BY APPLICATION (2020–2025)    37
FIGURE 13         DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS (2020–2025)   38
FIGURE 14         GEOGRAPHICAL SNAPSHOT OF THE DIGITAL THERAPEUTICS MARKET            39
FIGURE 15         INCREASING INCIDENCE OF CHRONIC DISEASES & TECHNOLOGICAL ADVANCEMENTS ARE DRIVING THE ADOPTION OF DIGITAL THERAPEUTICS           40
FIGURE 16         B2B SALES DOMINATE THE DIGITAL THERAPEUTICS MARKET              41
FIGURE 17         PAYERS HELD THE LARGEST SHARE OF THE MARKET, BY B2B SALES CHANNEL,
IN 2019 42
FIGURE 18         NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR DIGITAL THERAPEUTICS           43
FIGURE 19         DIGITAL THERAPEUTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    44
FIGURE 20         NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SNAPSHOT        79
FIGURE 21         EUROPE: DIGITAL THERAPEUTICS MARKET SNAPSHOT              90
FIGURE 22         KEY DEVELOPMENTS IN THE DIGITAL THERAPEUTICS MARKET            129
FIGURE 23         DIGITAL THERAPEUTICS MARKET RANKING ANALYSIS, 2019              130
FIGURE 24         DIGITAL THERAPEUTICS (DTX) MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 132

掲載企業リスト

プレスリリース

当レポートのプレスリリースは発行されておりません。

▲　ページトップへ

資料検索

お探しの資料・レポートをキーワードで検索ください。

当サイト内の検索結果が表示されます。調査レポートは英文目次を掲載しているため、英語検索も有効です。
（ブラウザのスクリプトを有効にしないとサーチエンジンが表示されません）


	お問い合わせお問合わせはこちらからレポートをお探しいたします。当サイトに掲載されているレポート以外にも幅広くご提案可能です。レポートの内容に関するご質問、ご確認にも回答いたします。お気軽にお問い合わせください。

デジタル治療(DTx)の世界市場：2025年に至る販売チャンネル別、用途別予測

Digital Therapeutic (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel (B2C, Patient, Caregiver, B2B, Providers, Payer, Employer, Pharma) - Global forecasts to 2025

英文詳細目次(table of contents)

【原文詳細目次】

Digital Therapeutic (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel (B2C, Patient, Caregiver, B2B, Providers, Payer, Employer, Pharma) - Global forecasts to 2025

1 INTRODUCTION 19

2 RESEARCH METHODOLOGY 22

3 EXECUTIVE SUMMARY 35

4 PREMIUM INSIGHTS 40

5 MARKET OVERVIEW 44

6 DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL 52

7 DIGITAL THERAPEUTICS MARKET, BY APPLICATION 61

8 DIGITAL THERAPEUTICS MARKET, BY REGION 77

9 COMPETITIVE LANDSCAPE 129

10 COMPANY PROFILES 135

LIST OF TABLES

LIST OF FIGURES

掲載企業リスト

プレスリリース

プレスリリース

関連レポート

創薬における人工知能(AI)の世界市場：技術別、用途別2024年予測

資料検索

お探しの資料・レポートをキーワードで検索ください。

お問い合わせ

お問合わせはこちらから